4-amino-5-(1,3-dioxoisoindol-2-yl)-5-oxopentanoic acid

Names

[ CAS No. ]:
102584-90-7

[ Name ]:
4-amino-5-(1,3-dioxoisoindol-2-yl)-5-oxopentanoic acid

[Synonym ]:
Valeric acid,4-amino-5-(1,3-dioxo-2-isoindolinyl)-5-oxo
N-Phthalyl-DL-isoglutamin
N-Phthalyl-DL-isoglutamin [German]
N-Phthalyl-D,L-isoglutamine

Chemical & Physical Properties

[ Molecular Formula ]:
C13H12N2O5

[ Molecular Weight ]:
276.24500

[ Exact Mass ]:
276.07500

[ PSA ]:
117.77000

[ LogP ]:
0.63950

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
YV6166000
CHEMICAL NAME :
Valeric acid, 4-amino-5-(1,3-dioxo-2-isoindolinyl)-5-oxo-
CAS REGISTRY NUMBER :
102584-90-7
LAST UPDATED :
198910
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C13-H12-N2-O5
MOLECULAR WEIGHT :
276.27
WISWESSER LINE NOTATION :
T56 BVNVJ CVYZ2VQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
200 mg/kg
SEX/DURATION :
female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
REFERENCE :
EXPEAM Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- Volume(issue)/page/year: 29,423,1973
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
900 mg/kg
SEX/DURATION :
female 6-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea)
REFERENCE :
JRPFA4 Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- Volume(issue)/page/year: 11,157,1966

Related Compounds

  • 7-ethoxy-6-methoxyquinazolin-4(3H)-one
  • 5-(1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperidin-4-yl)-1,3-oxazole-4-carboxylic acid
  • 1-(1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperidin-4-yl)-1H-1,2,3-triazole-5-carboxylic acid
  • 2-(1-{[(9H-fluoren-9-yl)methoxy]carbonyl}pyrrolidin-2-yl)-1,3-thiazole-4-carboxylic acid
  • 1-(9H-Fluoren-9-ylmethoxycarbonyl)-3-fluoro-4-phenylpyrrolidine-3-carboxylic acid
  • 1-(1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperidin-4-yl)-5-methyl-1H-pyrazole-4-carboxylic acid
  • 2(1H)-Pyridinone, 6-(hydroxymethyl)-5-(trifluoromethyl)-
  • 2-(1-Chloro-2-oxopropyl)-3-methoxyphenol
  • 2-(isopropylthio)-5-(pyridin-4-yl)-7,8,9,10-tetrahydropyrimido[4,5-b]quinoline-4,6(3H,5H)-dione
  • [(2S,5R)-5-Cyclopropyloxolan-2-yl]methanamine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.